… COVID-19 is the third emergence of a coronavirus in less than 20 years. Its clinical spectrum
… of COVID-19 patients, is a type of respiratory failure characterized by acute lung injury and …

… lung protection and virus replication not only in the pre-clinical phase, but that this cytokine
may still be double-dealing in the critical phase of COVID-19 … factor in lung protection and the …

… melatonin and vitamin D as a new potential synergistic treatment in COVID-19 lung infection:
The cross-talk between melatonin-RAS-vitamin D, a rational protagonist triad in COVID-19? …

… : the first immune defense-based protective phase and the second inflammation-driven …
Since Vitamin B3 is highly lung protective, it should be used as soon as coughing begins. …

… that patients who recover from COVID-19 may be at risk of … , lungs and gut, with
histopathological evidence of lung … not show any signs of COVID-19 disease recurrence. This …

… When confronting such an unfamiliar and rapidly evolving environment, only certain aspects
of well-accepted lung-protective approaches to ARDS remain rational at these different …

… lung protective efficacy and the today's urgent need for lung … of COVID-19 pneumonia
patients on ICUs with natural lung … reaction found in lung autopsies of COVID-19 patients (22). …

… The lung is the vital target organ of coronavirus disease 2019 (COVID-19) caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the majority of …

… of COVID-19–induced acute lung injury, angiotensin receptor blockade with maximal dose
losartan did not reduce lung … did not reduce lung injury in patients with COVID-19 and raised …

… In these patients, lung protective ventilation is essential. Severe pneumonia in COVID-19
differs … very high case fatality rate of more than 50% in invasively ventilated COVID-19 patients. …